KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Revenue (2016 - 2025)

Evolent Health (EVH) has 11 years of Revenue data on record, last reported at -$19.0 million in Q4 2025.

  • For Q4 2025, Revenue fell 102.94% year-over-year to -$19.0 million; the TTM value through Dec 2025 reached $1.4 billion, down 45.65%, while the annual FY2025 figure was -$57.5 million, 102.25% down from the prior year.
  • Revenue reached -$19.0 million in Q4 2025 per EVH's latest filing, down from $479.5 million in the prior quarter.
  • Across five years, Revenue topped out at $647.1 million in Q2 2024 and bottomed at -$19.0 million in Q4 2025.
  • Average Revenue over 5 years is $408.4 million, with a median of $436.0 million recorded in 2023.
  • Peak YoY movement for Revenue: surged 58.49% in 2022, then tumbled 102.94% in 2025.
  • A 5-year view of Revenue shows it stood at $248.4 million in 2021, then soared by 53.98% to $382.4 million in 2022, then skyrocketed by 45.4% to $556.1 million in 2023, then rose by 16.27% to $646.5 million in 2024, then plummeted by 102.94% to -$19.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were -$19.0 million in Q4 2025, $479.5 million in Q3 2025, and $444.3 million in Q2 2025.